Primary liver carcinoma exhibiting dual hepatocellular-biliary epithelial differentiations associated with citrin deficiency: A case report

Journal of Clinical Gastroenterology

Volumn 42, Issue 7, 2008, Pages 855-860

  Soeda, Junpei ^a   Yazaki, Masahide ^a   Nakata, Takenari ^a   Miwa, Shiro ^a   Ikeda, Shu Ichi ^a   Hosoda, Waki ^a   Iijima, Mikio ^b   Kobayashi, Keiko ^b   Saheki, Takeyori ^b   Kojiro, Masamichi ^c   Miyagawa, Shin Ichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adult onset type II citrullinemia; Cholangiocellular carcinoma; Citrin deficiency; Hepatocellular carcinoma; Primary liver carcinoma

Indexed keywords

APROTININ; ARGININE; BRANCHED CHAIN AMINO ACID; CARCINOEMBRYONIC ANTIGEN; CEFMETAZOLE; CITRULLINE; DNA; FRESH FROZEN PLASMA; LACTULOSE; RANITIDINE;

ADULT; ARTICLE; BILE DUCT; BILE DUCT CARCINOMA; CASE REPORT; CELL DIFFERENTIATION; CITRULLINEMIA; COLON POLYP; DISEASE ASSOCIATION; DNA DETERMINATION; EPITHELIUM CELL; FATTY LIVER; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CARCINOMA; LIVER CELL; LIVER FUNCTION; LIVER RESECTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; BILE DUCT TUMOR; CYTOLOGY; INTRAHEPATIC BILE DUCT; LIVER; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER TUMOR; MIDDLE AGED; PATHOLOGY;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CHOLANGIOCARCINOMA; CITRULLINEMIA; HEPATECTOMY; HUMANS; LIVER; LIVER FAILURE; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 44449175312     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000225683.29841.9c     Document Type: Article

References (36)

1. Brusilow SW, Horwich AL. Urea cycle enzymes. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th ed. New York: McGraw-Hill; 1995: 1187-1232.
2. Saheki T, Kobayashi K, Inoue I. Hereditary disorders of the urea cycle in man: biochemical and molecular approach. Rev Physiol Biochem Pharmacol. 1987;108:21-68.
3. Kobayashi K, Sinasac DS, Iijima M, et al. The gene mutated in adult-onset type II citrullinemia encodes a putative mitochondrial carrier protein. Nature Genet. 1999;22:159-163.
4. Ikeda S, Yazaki M, Takei Y, et al. Type II (adult onset) citrullinaemia: clinical pictures and the therapeutic effect of liver transplantation. J Neurol Neurosurg Psychiatry. 2001;71:663-670.
5. Ohura T, Kobayashi K, Tazawa Y, et al. Neonatal presentation of adult-onset type II citrullinemia. Hum Genet. 2001;108:87-90.
6. Tazawa Y, Kobayashi K, Ohura T, et al. Infantile cholestatic jaundice associated with adult-onset type II citerullinemia. J Pediatr. 2001;138:735-740.
7. Saheki T, Kobayashi K. Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD). J Hum Genet. 2002;47:333-341.
8. Ikeda S, Kawa S, Takei Y, et al. Chronic pancreatitis associated with adult-onset type II citrullinemia: clinical and pathological findings. Ann Intern Med. 2004;141:W109-W110.
9. Arimura A, Azegami N, Yoshimura H, et al. An autopsied case of adult type citrullinemia complicated with large hepatocellular carcinoma. Kanzo. 1991;32:793-797 (in Japanese).
10. Takamizawa M, Toru M, Kojima T, et al. An autopsy case of juvenile hepato-cerebral degeneration (non-Wilsonian Inose-type) with mental retardation, with special reference to ammonia and amino acids metabolism. Seishinshinkeigaku. 1973;77:370-382 (in Japanese).
11. Fukuda S, Ohkawa M, Yoshida Y, et al. A case of citrullinemia. Kantansui. 1984;8:439-446 (in Japanese).
12. Tanaka T, Nagao M, Tsutsumi H. Application of mutation analysis for the previously uncertain cases of adult-onset type II citrullinemia (CTLN2) and their clinical profiles. Tohuku J Exp Med. 2002; 198:89-97.
13. Itakura Y, Oyanagi K, Tsuchiyama A, et al. Localization of argininosuccinate synthetase in the liver of adult type citrullinemia complicated with hepatoma. Igakunoayumi. 1984;130:733-734 (in Japanese).
14. Watanabe S, Takeda I, Ohkura Y, et al. An adult-type citrullinemia with chronic hepatitis type B who died from hepatoma in a short term with paraneoplastic syndrome. Kanzo. 1991;32:295-299 (in Japanese).
15. Tsujii T, Morita T, Matsuyama Y, et al. Sibling cases of chronic recurrent hepatocerebral disease with hypercitrullinemia. Gastroenterologia Japonica. 1976;11:328-340.
16. Okeda R, Tanaka M, Kawahara Y, et al. Adult-type citrullinemia. Acta Neuropathol. 1989;78:96-100.
17. Takahashi K, Kishikawa M, Fujii H, et al. A case of combined pseudoulegyric type hepatocerebral disease and Pick's disease. Seishinkashindangaku. 1990;2:121-132 (in Japanese).
18. Ito T, Shiraki K, Sekoguchi K, et al. Hepatocellular carcinoma associated with adult-type citrullinemia. Dig Dis Sci. 2000;45: 2203-2206.
19. Hagiwara N, Sekijima Y, Takei Y, et al. Hepatocellular carcinoma in a case of adult-onset type II citrullinemia. Intern Med. 2003;42: 978-982.
20. Kanayama M, Ishii K, Wakui N, et al. A case of type II citrullinemia diagnosed 3 years after right lobectomy for Hepato-cellular carcinoma. Kanzo. 2004;45:542-548 (in Japanese).
21. Goodman ZD, Ishak KG, Langloss JM, et al. Combined hepatocellular- cholangiocarcinoma. A histologic and immunohistochemical study. Cancer. 1985;55:124-135.
22. Haratake J, Hashimoto H. An immunohistochemical analysis of 13 cases with combined hepatocellular and cholangiocellular carcinoma. Liver. 1995;15:9-15.
23. Taguchi J, Nakashima O, Tanaka M, et al. A clinicopathological study on combined hepatocellular and cholangiocarcinoma. J Gastoenterol Hepatol. 1996;11:758-764.
24. Kim H, Park C, Han KH, et al. Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype. J Hepatol. 2004;40:298-304.
25. Tanaka K, Honna T, Kitano Y, et al. Combined fibrolamellar carcinoma and cholangiocarcinoma exhibiting biphenotypic antigen expression: a case report. J Clin Pathol. 2005;58:884-887.
26. Kobayashi K, Horiuchi M, Saheki T. Pancreatic secretory trypsin inhibitor as a diagnostic marker for adult-onset type II citrullinemia. Hepatology. 1997;25:1160-1165.
27. Yasuda T, Yamaguchi N, Kobayashi K, et al. Identification of two novel mutations in the SLC25A13 gene and detection of seven mutations in 102 patients with adult-onset type II citrullinemia. Hum Genet. 2000;107:537-545.
28. Imamura Y, Kobayashi K, Shibatou T, et al. Effectiveness of carbohydrate-restricted diet and arginine granules therapy for adultonset type II citrullinemia: a case report of siblings showing homozygous SLC25A13 mutation with and without the disease. Hepatol Res. 2003;26:68-72.
29. Baumann U, Crosby HA, Ramani P, et al. Expression of stem cell receptor c-kit in normal and disease pediatric liver. Hepatology. 1999;30:112-117.
30. Kobayashi K, Iijima M, Yasuda T, et al. Type II citrullinemia (citrin deficiency): A mysterious disease caused by a defect of calcium-binding mitochondrial carrier protein. In: Pochet R, Donato R, Haiech J, et al, eds. Calcium: The Molecular Basis of Calcium Action in Biology and Medicine. Netherlands: Kluwer Academic Publishers; 2000:565-587.
31. Lee RG. Diagnostic Liver Pathology. St Louis: Mosby; 1994.
32. Cazals-Hatem D, Rebouissou S, Bioulac-Sage P, et al. Clinical and molecular analysis of combined hepatocellular-chorangiocarcinomas. J Hepatol. 2004;41:292-298.
33. 2+-stimulated aspartate/glutamate transporters in mitochondria. EMBO J. 2001;20:5060-5069.
34. Nakayama M, Okamoto Y, Morita T, et al. Promoting effect of citrulline in hepatocarcinogenesis: possible mechanism in hyper-citrullinemia. Hepatology. 1990;11:819-823.
35. Harrison SA, Kadakia S, Lang KA, et al. Nonalcoholic steatohe-patitis: what we know in the new millennium. Am J Gastroenterol. 2002;97:2714-2724.
36. Takagi H, Hagiwara S, Hashizume H, et al. Adult onset type II citrullinemia as a cause of non-alcoholic steatohepatitis. J Hepatol. 2006;44:236-239.